Ning, Shoucheng <br/><br/>
Lanreotide promotes apoptosis and is not radioprotective in GH3 cells.  [electronic resource] 

 -  Endocrine-related cancer  Sep 2009 
 - 1045-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-6821 
<br/><br/><label>Standard No.: </label>10.1677/ERC-09-0003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--pathology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Gamma Rays<br/>Growth Hormone-Secreting Pituitary Adenoma--pathology<br/>Male<br/>Mice<br/>Mice, Nude<br/>Peptides, Cyclic--pharmacology<br/>Radiation Dosage<br/>Radiation Tolerance--drug effects<br/>Radiation-Protective Agents--pharmacology<br/>Rats<br/>Somatostatin--analogs & derivatives<br/>Somatotrophs--drug effects<br/>Xenograft Model Antitumor Assays